Comparison of Angioplasty with Stenting, with or without Abciximab, in Acute Myocardial Infarction

W. Stone, Gregg; L. Grines, Cindy; A. Cox, David; Garcı́a, Eulogio; E. Tcheng, James; J. Griffin, John; Guagliumi, Giulio; Stuckey, Thomas; Turco, Mark; D. Carroll, John; D. Rutherford, Barry; J. Lansky, Alexandra

doi:10.1056/nejmoa013404

Public

Comparison of Angioplasty with Stenting, with or without Abciximab, in Acute Myocardial Infarction

Published in New England Journal of Medicine • Mar 28, 2002

Authors:

Gregg W. Stone

Cindy L. Grines

David A. Cox

Abstract

BACKGROUND: As compared with thrombolytic therapy, primary percutaneous transluminal coronary angioplasty (PTCA) in acute myocardial infarction reduces the rates of death, reinfarction, and stroke, but recurrent ischemia, restenosis, and reocclusion of the infarct-related artery remain problematic. ...

Subject

Medicine

Abciximab

Cardiology

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!